Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Fogo de Chão, Inc. Initial Public Offering
Davis Polk advised Fogo de Chão, Inc. (“Fogo”) on its $101.5 million initial public offering of 5,073,528 shares of its…
Fogo de Chão, Inc. Initial Public Offering
Davis Polk advised Fogo de Chão, Inc. (“Fogo”) on its $101.5 million initial public offering of 5,073,528 shares of its…
Fogo de Chão, Inc. Initial Public Offering
Davis Polk advised Fogo de Chão, Inc. (“Fogo”) on its $101.5 million initial public offering of 5,073,528 shares of its…
Ctrip.com International, Ltd. $1.1 Billion Convertible Bonds Offering
Davis Polk advised the initial purchasers in a Rule 144A and Regulation S offering by Ctrip.com International, Ltd. of $700…
Ctrip.com International, Ltd. $1.1 Billion Convertible Bonds Offering
Davis Polk advised the initial purchasers in a Rule 144A and Regulation S offering by Ctrip.com International, Ltd. of $700…
Ctrip.com International, Ltd. $1.1 Billion Convertible Bonds Offering
Davis Polk advised the initial purchasers in a Rule 144A and Regulation S offering by Ctrip.com International, Ltd. of $700…
Davis Polk Advises Pandox AB on Its SEK6.36 Billion (US$780 Million) Initial Public Offering
Davis Polk advised Pandox Aktiebolag (publ) on its initial public offering and listing of B Shares on NASDAQ Stockholm…
Cynapsus Therapeutics Inc. $72.5 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $72.5 million U.S. initial public offering of 5,175,000 common…
Cynapsus Therapeutics Inc. $72.5 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $72.5 million U.S. initial public offering of 5,175,000 common…
Cynapsus Therapeutics Inc. $72.5 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $72.5 million U.S. initial public offering of 5,175,000 common…